BindingDB logo
myBDB logout

null

SMILES: O=C(Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1)NCCOc1ccncc1

InChI Key:

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 493103   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK1 [574-1154]


(Homo sapiens (Human))
BDBM493103
PNG
(2-(1-((1r,4r)-4-(Cyanomethyl)cyclohexyl)-1,6-dihyd...)
Show SMILES O=C(Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1)NCCOc1ccncc1 |r,wU:18.21,wD:15.17,(-2.41,-1.63,;-1.64,-.29,;-.1,-.29,;.67,-1.63,;.05,-3.03,;1.19,-4.06,;1.19,-5.6,;2.52,-6.37,;3.86,-5.6,;5.32,-6.08,;6.23,-4.83,;5.32,-3.59,;3.86,-4.06,;2.52,-3.29,;2.2,-1.79,;3.23,-.64,;4.74,-.96,;5.77,.18,;5.29,1.64,;6.33,2.79,;7.83,2.47,;9.34,2.15,;3.79,1.97,;2.76,.82,;-2.41,1.04,;-3.95,1.04,;-4.72,2.37,;-6.26,2.37,;-7.03,3.71,;-6.26,5.04,;-7.03,6.37,;-8.57,6.37,;-9.34,5.04,;-8.57,3.71,)|
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)

More data for this
Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2 [580-1182,C936A,C1142A]


(Homo sapiens (Human))
BDBM493103
PNG
(2-(1-((1r,4r)-4-(Cyanomethyl)cyclohexyl)-1,6-dihyd...)
Show SMILES O=C(Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1)NCCOc1ccncc1 |r,wU:18.21,wD:15.17,(-2.41,-1.63,;-1.64,-.29,;-.1,-.29,;.67,-1.63,;.05,-3.03,;1.19,-4.06,;1.19,-5.6,;2.52,-6.37,;3.86,-5.6,;5.32,-6.08,;6.23,-4.83,;5.32,-3.59,;3.86,-4.06,;2.52,-3.29,;2.2,-1.79,;3.23,-.64,;4.74,-.96,;5.77,.18,;5.29,1.64,;6.33,2.79,;7.83,2.47,;9.34,2.15,;3.79,1.97,;2.76,.82,;-2.41,1.04,;-3.95,1.04,;-4.72,2.37,;-6.26,2.37,;-7.03,3.71,;-6.26,5.04,;-7.03,6.37,;-8.57,6.37,;-9.34,5.04,;-8.57,3.71,)|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.70n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK3 [512-1124]


(Homo sapiens (Human))
BDBM493103
PNG
(2-(1-((1r,4r)-4-(Cyanomethyl)cyclohexyl)-1,6-dihyd...)
Show SMILES O=C(Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1)NCCOc1ccncc1 |r,wU:18.21,wD:15.17,(-2.41,-1.63,;-1.64,-.29,;-.1,-.29,;.67,-1.63,;.05,-3.03,;1.19,-4.06,;1.19,-5.6,;2.52,-6.37,;3.86,-5.6,;5.32,-6.08,;6.23,-4.83,;5.32,-3.59,;3.86,-4.06,;2.52,-3.29,;2.2,-1.79,;3.23,-.64,;4.74,-.96,;5.77,.18,;5.29,1.64,;6.33,2.79,;7.83,2.47,;9.34,2.15,;3.79,1.97,;2.76,.82,;-2.41,1.04,;-3.95,1.04,;-4.72,2.37,;-6.26,2.37,;-7.03,3.71,;-6.26,5.04,;-7.03,6.37,;-8.57,6.37,;-9.34,5.04,;-8.57,3.71,)|
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 87.4n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2 [532-1132]


(Homo sapiens (Human))
BDBM493103
PNG
(2-(1-((1r,4r)-4-(Cyanomethyl)cyclohexyl)-1,6-dihyd...)
Show SMILES O=C(Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1)NCCOc1ccncc1 |r,wU:18.21,wD:15.17,(-2.41,-1.63,;-1.64,-.29,;-.1,-.29,;.67,-1.63,;.05,-3.03,;1.19,-4.06,;1.19,-5.6,;2.52,-6.37,;3.86,-5.6,;5.32,-6.08,;6.23,-4.83,;5.32,-3.59,;3.86,-4.06,;2.52,-3.29,;2.2,-1.79,;3.23,-.64,;4.74,-.96,;5.77,.18,;5.29,1.64,;6.33,2.79,;7.83,2.47,;9.34,2.15,;3.79,1.97,;2.76,.82,;-2.41,1.04,;-3.95,1.04,;-4.72,2.37,;-6.26,2.37,;-7.03,3.71,;-6.26,5.04,;-7.03,6.37,;-8.57,6.37,;-9.34,5.04,;-8.57,3.71,)|
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.10n/an/an/an/an/an/a



Janssen Pharmaceutica NV

US Patent


Assay Description
11-point dosing series were made for each compound by serially diluting 1:3 or 1:4 in DMSO, with point 12 being a DMSO control. From the serial dilut...


US Patent US10981911 (2021)

More data for this
Ligand-Target Pair